RxDoctor Payments DataLook up a doctor →

Jeffrey Taylor, NP

Family · Johnson City, TNNPI 1518329028

Payments from drug & device makers

$24,559in general payments, 2019–2025

Across 930 payments — averaging $26.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$3K
  • Johnson & Johnson$2K
  • G1 Therapeutics, Inc.$1K
  • AstraZeneca$1K
  • Merck$1K
  • E.r. Squibb & Sons, L.L.C.$1K
  • plus $14K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis72$3,168
Johnson & Johnson(2 entities)69$1,738
G1 Therapeutics, Inc.9$1,492
AstraZeneca(2 entities)63$1,483
Merck54$1,361
E.r. Squibb & Sons, L.L.C.71$1,287
Daiichi Sankyo Inc.43$957
Incyte Corporation37$907
Astellas Pharma US Inc34$830
Bristol Myers Squibb26$679
Lilly USA, LLC33$637
Amgen27$627
Genentech USA, Inc.30$571
Sanofi27$568
Pfizer29$558
Seagen Inc.16$503
AbbVie13$492
Eisai Inc.20$465
Takeda Pharmaceuticals U.S.A., Inc.16$452
Regeneron Healthcare Solutions, Inc.15$451
Bayer24$413
Gilead(2 entities)18$365
Beigene USA, Inc.15$350
Exelixis Inc.12$315
AVEO Pharmaceuticals, Inc.8$287
Ipsen Biopharmaceuticals, Inc9$239
GSK7$238
Sobi, Inc5$212
EMD Serono, Inc.10$194
Tersera Therapeutics LLC8$161
Sanofi-aventis U.S. LLC2$160
Epizyme, Inc.5$154
Jazz Pharmaceuticals Inc.4$145
Mirati Therapeutics, Inc.4$140
Boehringer Ingelheim6$130
Genmab U.S., Inc.6$127
Array Biopharma Inc9$124
Pharmacyclics LLC, An Abbvie Company7$116
Morphosys, US Inc.4$108
Beone Medicines USA, Inc.5$105
Myriad Genetic Laboratories, Inc.7$103
Puma Biotechnology, Inc.1$89
Karyopharm Therapeutics Inc.4$84
Intuitive Surgical1$82
Taiho Oncology, Inc.5$81
Rigel Pharmaceuticals, Inc.4$71
Iovance Biotherapeutics, Inc.2$58
Pharmaessentia USA Corporation2$50
Kyowa Kirin, Inc.3$48
Servier Pharmaceuticals LLC2$47
Caris MPI, Inc.2$41
Verity Pharmaceuticals Inc.2$39
Geron Corporation2$39
Saluda Medical Americas, Inc.1$37
Agios Pharmaceuticals, Inc.2$33
Apellis Pharmaceuticals, Inc.2$33
Tempus AI, Inc1$29
Foundation Medicine, Inc.1$27
Alnylam Pharmaceuticals Inc.1$26
Corcept Therapeutics1$26

How this compares

$24,559 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee →

Medicare billing

Part B allowed, 2024
$114,894
Medicare patients
117
Services billed
5,628

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Johnson City

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →